The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 15, 2016

Filed:

Jul. 30, 2014
Applicant:

GE Healthcare Dharmacon, Inc., Lafayette, CO (US);

Inventors:

Melissa Kelley, Lafayette, CO (US);

Amanda Birmingham, Lafayette, CO (US);

Jon Karpilow, Boulder, CO (US);

Anastasia Khvorova, Northborough, MA (US);

Kevin Sullivan, Boulder, CO (US);

Assignee:

GE Healthcare Dharmacon, Inc., Lafayette, CO (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12Q 1/68 (2006.01); C12N 15/113 (2010.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); C12N 15/111 (2013.01); C12Q 1/6869 (2013.01); C12N 2310/141 (2013.01); C12N 2310/531 (2013.01); C12N 2320/30 (2013.01); C12N 2330/30 (2013.01);
Abstract

The present disclosure provides a non-naturally occurring miRNA having a stem-loop structure comprising a scaffold derived from a first endogenous miRNA (e.g., miR-196a-2 or miR-204), a mature strand derived from a second endogenous miRNA, and a star strand sequence that is at least partially complementary to the mature strand sequence. The present disclosure also provides a non-naturally occurring miRNA having a stem-loop structure comprising a scaffold derived from an endogenous miRNA (e.g., miR-196a-2 or miR-204), a mature strand designed to be at least partially complementary to a target RNA, and a star strand sequence that is at least partially complementary to the mature strand sequence. The methods and compositions of the disclosure may be used to mediate gene silencing via the RNAi pathway.


Find Patent Forward Citations

Loading…